- Home
- GEVO vs SIGA Comparison
GEVO vs SIGA Comparison
Compare GEVO & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEVO | SIGA |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.1M | 421.8M |
| IPO Year | 2011 | 1997 |
Fundamental Metrics
Financial Performance| Metric | GEVO | SIGA |
|---|---|---|
| Price | $2.31 | $6.19 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.13 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 455.0K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 9.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | $120,932,000.00 | ★ $172,249,641.00 |
| Revenue This Year | $927.85 | N/A |
| Revenue Next Year | $12.01 | $132.36 |
| P/E Ratio | ★ N/A | $6.02 |
| Revenue Growth | ★ 675.75 | N/A |
| 52 Week Low | $0.92 | $4.95 |
| 52 Week High | $2.98 | $9.62 |
Technical Indicators
Market Signals| Indicator | GEVO | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 59.05 | 39.45 |
| Support Level | $1.83 | $5.85 |
| Resistance Level | $2.42 | $6.15 |
| Average True Range (ATR) | 0.12 | 0.22 |
| MACD | 0.04 | 0.11 |
| Stochastic Oscillator | 79.66 | 71.88 |
Price Performance
Historical ComparisonAbout GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.